Results 211 to 220 of about 333,809 (260)
Some of the next articles are maybe not open access.
Hematological Oncology, 2023
AbstractThe treatment of peripheral T‐cell lymphomas is challenging, as they often display a severe prognosis and lack effective treatment strategies. We will try to answer three burning questions: can we differentiate the initial treatment based on the histotype and the clinical presentation of peripheral T‐cell lymphoma patients?
Broccoli A., Zinzani P. L.
openaire +3 more sources
AbstractThe treatment of peripheral T‐cell lymphomas is challenging, as they often display a severe prognosis and lack effective treatment strategies. We will try to answer three burning questions: can we differentiate the initial treatment based on the histotype and the clinical presentation of peripheral T‐cell lymphoma patients?
Broccoli A., Zinzani P. L.
openaire +3 more sources
T-cell therapies for T-cell lymphoma
Cytotherapy, 2019T-cell lymphomas represent a subpopulation of non-Hodgkin lymphomas with poor outcomes when treated with conventional chemotherapy. A variety of novel agents have been introduced as new treatment strategies either as first-line treatment or in conjunction with chemotherapy. Immunotherapy has been demonstrated to be a promising area for new therapeutics,
Keri Toner +2 more
openaire +2 more sources
Angioimmunoblastic T‐cell lymphoma
British Journal of Haematology, 2003Angioimmunoblastic T-cell lymphoma (AITL) is one of the most common types of T-cell lymphoma, representing about 15–20% of cases of peripheral T-cell lymphoma (PTCL). It is characterized by a unique clinical presentation and distinct pathologic and molecular features.
Ahmet, Dogan +2 more
openaire +2 more sources
Journal of the European Academy of Dermatology and Venereology, 2003
ABSTRACTCutaneous T‐cell lymphoma (CTCL) is a neoplasm of helper T cells whose first manifestations usually appear in the skin. The various forms of CTCL are distinguished by both clinical features and histopathology. Early on, the diagnosis may be difficult to establish because of its numerous, and often non‐specific, clinical presentations.
E A, Kotz, D, Anderson, B H, Thiers
openaire +2 more sources
ABSTRACTCutaneous T‐cell lymphoma (CTCL) is a neoplasm of helper T cells whose first manifestations usually appear in the skin. The various forms of CTCL are distinguished by both clinical features and histopathology. Early on, the diagnosis may be difficult to establish because of its numerous, and often non‐specific, clinical presentations.
E A, Kotz, D, Anderson, B H, Thiers
openaire +2 more sources
Hematology/Oncology Clinics of North America, 2008
Cutaneous T-cell lymphoma comprises a heterogeneous group of lymphoproliferative disorders characterized by clonal expansions of mature, post-thymic T cells that infiltrate the skin. This article discusses the staging, prognosis, and treatment of mycosis fungoides and Sézary syndrome.
Frederick, Lansigan +2 more
openaire +2 more sources
Cutaneous T-cell lymphoma comprises a heterogeneous group of lymphoproliferative disorders characterized by clonal expansions of mature, post-thymic T cells that infiltrate the skin. This article discusses the staging, prognosis, and treatment of mycosis fungoides and Sézary syndrome.
Frederick, Lansigan +2 more
openaire +2 more sources
Histopathology, 1986
In Europe and North America T-cell leukaemias and lymphomas are uncommon compared with tumours of B-lymphocytes although this disparity is probably exaggerated by under-recognition. Some neoplasms of T-lymphocytes have been reasonably well defined clinically and histologically.
openaire +2 more sources
In Europe and North America T-cell leukaemias and lymphomas are uncommon compared with tumours of B-lymphocytes although this disparity is probably exaggerated by under-recognition. Some neoplasms of T-lymphocytes have been reasonably well defined clinically and histologically.
openaire +2 more sources
The Journal of Dermatology, 1980
AbstractCutaneous T cell lymphoma (CTCL) is a generic classification of clonally‐derived malignancies of phenotypic helper/inducer T cells with a propensity to infiltrate the skin, migrate into the epidermis, localize in T cell zones of lymphoid structures and spare the bone marrow.
openaire +3 more sources
AbstractCutaneous T cell lymphoma (CTCL) is a generic classification of clonally‐derived malignancies of phenotypic helper/inducer T cells with a propensity to infiltrate the skin, migrate into the epidermis, localize in T cell zones of lymphoid structures and spare the bone marrow.
openaire +3 more sources
Expert Review of Anticancer Therapy, 2010
The T-cell Lymphoma Forum was held from 28-30 January, 2010, in Maui, HI, USA. The meeting provided a venue for clinicians and scientists to discuss the science and treatment of T-cell and natural killer (NK)-cell lymphomas. Different subtypes of T-cell and NK-cell lymphomas have different epidemiologic and clinicopathologic characteristics. T-cell and
openaire +4 more sources
The T-cell Lymphoma Forum was held from 28-30 January, 2010, in Maui, HI, USA. The meeting provided a venue for clinicians and scientists to discuss the science and treatment of T-cell and natural killer (NK)-cell lymphomas. Different subtypes of T-cell and NK-cell lymphomas have different epidemiologic and clinicopathologic characteristics. T-cell and
openaire +4 more sources
Medical Clinics of North America, 1982
Cutaneous T cell lymphoma is a malignancy of helper T cells, which have a propensity to infiltrate the skin. The incidence of the disease appears to exceed that of Hodgkin's disease, making it the most common lymphoma of adults. Advances in our knowledge of the biology of the malignant T cells should facilitate new and more effective forms of treatment.
J A, Patterson, R L, Edelson
openaire +2 more sources
Cutaneous T cell lymphoma is a malignancy of helper T cells, which have a propensity to infiltrate the skin. The incidence of the disease appears to exceed that of Hodgkin's disease, making it the most common lymphoma of adults. Advances in our knowledge of the biology of the malignant T cells should facilitate new and more effective forms of treatment.
J A, Patterson, R L, Edelson
openaire +2 more sources
Angioimmunoblastic T-Cell Lymphoma
2018Angioimmunoblastic T-cell lymphoma (AITL) is one of the most common types of T-cell lymphoma, representing about 15-20% of cases of peripheral T-cell lymphoma (PTCL). It is characterized by a unique clinical presentation and distinct pathologic and molecular features.
Mariko, Yabe +3 more
openaire +2 more sources